Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

Completed

Conditions studied: Hereditary Cancer

In brief

A prospective, non-interventional study to evaluate the impact of a process engineering intervention on screening and testing outcomes for common hereditary cancer syndromes in community-based OB/GYN settings.

Key facts

Study ID

NCT03081455

Run by

Myriad Genetic Laboratories, Inc.

People needed

145

Starts

2017-02-13

Expected to finish

2017-08-04

Last updated by the study team

2017-08-08

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Patient who presents for a new patient gynecologic visit, well woman exam, or problem gynecologic visit and meets guidelines (HBOC-NCCN guidelines; Lynch syndrome-SGO/ACOG guidelines) for genetic testing
• Patient who is 18 years of age or older
• Able to understand informed consent and agrees to participate

You may not qualify if…

• Patient who has previously undergone BRCA1/2, Lynch syndrome genetic testing, or multi-gene, pan-cancer, or panel testing
• Patient who is not pregnant
• Patient who is unwilling or unable to provide informed consent.

Where it is running

• Westwood Women's Health — Waterbury, Connecticut, United States
• Associates for Women's Medicine — Syracuse, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.